News: Indonesia

12 August 2022

The Ministry of Health Continues to Encourage the Use of Phytopharmaceuticals in Health Service Facilities

The government primarily focuses on developing phytopharmaceuticals to create a system of health resilience and domestic pharmaceutical self-reliance. Launching the Phytopharmaca Formulary and promoting its usage in medical institutions are examples of the government's commitment to fostering the use of phytopharmaceuticals. The Director General of Pharmaceuticals and Medical Devices at…
5 August 2022

Dexa Group's Commitment to Encourage the Production of Natural Medicine Raw Materials for National Independence

With more than 28000 plant species and 2,848 medicinal plants, Indonesia has the second-highest biodiversity in the world. Its natural resources hold tremendous promise for developing phytopharmaceuticals and herbal medicines, including Indonesia Indigenous Modern Medicine (IIMM). Penny K. Lukito, head of the Food and Drug Supervisory Agency (BPOM), stated that…
1 August 2022

Dexa Award Science Scholarship 2022 Stimulates Innovation to Build Health Independence

The Indonesian government continues to encourage the resilience and independence of the healthcare industry, as imports dominate 90% of its domestic pharmaceutical raw materials and health spending. In addition, 88% of medical device transactions through electronic catalogs (e-catalogs) are imported products. Meanwhile, research and development funds are only about 0.2%…
8 July 2022

Prevent Stunting, Dexa Group's Green Pharmacy Becomes The Partner of BKKBN

Indonesia's 29th National Family Day (Harganas) was celebrated with the theme "Let's Prevent Stunting for Stunting-Free Family". President Joko Widodo (Jokowi) said that the government had appointed the National Population and Family Planning Agency (BKKBN) to reduce the prevalence of stunting to 14% in 2024. Therefore, BKKBN collaborates with several…
6 July 2022

Mr. Ferry A. Soetikno as a Speaker at the Advisory Board Sharing Session #7: Drug Raw Material Independence as a Part of the Dynamics of the Indonesian Pharmaceutical Industry

The Covid-19 epidemic has given Indonesia's pharmaceutical sector a fresh start. In stark contrast to the average 5–10% growth rate, the pharmaceutical sector shrank by -1.6 percent. Meanwhile, a supply shock made it challenging for the nation to get medical raw materials (BBO) since imports met 90% of BBO requirements.…
1 July 2022

Actively Contributing to Overcoming Health Problems, Dexa Group Wins Indonesia Best CSR Award 2022

Dexa Group received the Outstanding Program in Prioritizing Public Health Needs award from Warta Ekonomi's Indonesia Best CSR Award 2022 for its contribution to the healthcare industry. This honor is granted in recognition of Dexa Group's significant work putting social responsibility and environmental responsibility initiatives into action. On Thursday, June…
25 June 2022

The 'Bangga Buatan Indonesia' Movement Promotes Pharmacy Product Independence

Dexa Group participated in the Proudly Made in Indonesia 2022 event once more to accelerate the independence of domestic local products. On Thursday, June 23, 2022, the Bangga Buatan Indonesia (BBI) event with the title Lagawi Fest (Lampung Bangga Wirausaha Industri Festival) Satu Bumi Juta Karya was held on Tegal…
14 June 2022

STIMUNO Wins Top Brand For Kids for the 12th Time

STIMUNO has served as Indonesia's first phytopharmaceutical immunomodulator for over two decades. It also has won several honors since its initial release in 1999. For the 12th year in a row, STIMUNO syrup won the Top Brand For Kids Awards in the Children's Immune System Vitamins category. Marketing Magazine and…
9 June 2022

35 Health Offices in Central Java Support the Use of Indonesian Indigenous Modern Medicines

The ‘Bangga Buatan Indonesia’ Movement (BBI) is supported by 35 District/City Health Offices in Central Java Province, which provide the Special Allocation Fund (DAK) and the APBD for health expenditure on Indonesian Indigenous Modern Medicines (OMAI). Thie program is not just to comply with Presidential Instruction (Inpres) No. 2 of…
20 May 2022

Dexa Group Wins IMACO Awards 2022 for Consistently Developing Indonesian Indigenous Modern Medicines Product Innovations

Dexa Group, was named the Indonesia Most Acclaimed Company (IMACO) 2022 in the Healthcare Industry category for Outstanding Corporate Strategy for Innovative Business by Warta Ekonomi. This award validates Dexa Group's commitment as a national pharmaceutical company to continue innovating via competitive product research and development to achieve pharmaceutical independence.…
1 2 3 9